Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 364

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 2
Chunk 364
---
$%(dollars in thousands)Research and development$36,681 $33,475 $3,206 10 %Sales and marketing19,714 15,431 4,283 28 %General and administrative13,683 13,436 247 2 %Total operating expenses$70,078 $62,342 $7,736 12 %

Research and development expenses

R&D expenses increased by $3.2 million, or 10%, to $36.7 million for the nine months ended September 30, 2025 from $33.5 million for the nine months ended September 30, 2024. The increase in R&D expenses was due to higher employee-related costs of $2.3 million mainly driven by increased headcount to support growth of our business, including stock-based compensation expense. We also incurred higher professional fees of $0.4 million and received lower grants of $0.2 million by our subsidiary in France for R&D projects.

31

Sales and marketing expenses

S&M expenses increased by $4.3 million or 28%, to $19.7 million for the nine months ended September 30, 2025 from $15.4 million for the nine months ended September 30, 2024. The increase in S&M expenses was primarily due to higher employee-related costs of $3.6 million mainly driven by increased headcount to support growth of our business and higher stock-based compensation expense.

General and administrative expenses

G&A expenses remained relatively flat for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024.

Interest expense

Nine Months Ended September 30,Change20252024$%(dollars in thousands)Interest expense$(139)$(199)$60 (30)%

Interest expense remained relatively flat for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024.

Other income (expense), net

Nine Months Ended September 30,Change20252024$%(dollars in thousands)Other income (expense), net$2,140 $2,576 $(436)(17)%

Other income (expense), net decreased by $0.4 million, or 17%, to $2.1 million for the nine months ended September 30, 2025, from $2.6 million for the nine months ended September 30, 2024